Diamonds and Dogs
Eli Lilly (LLY) is fighting back. The drug maker is up 3% back near its 52-week high after reaffirming guidance and raising 2020 outlook. Eli Lilly is seeing improved productivity and important data readouts for several investigational medicines in its clinical pipeline and the possibility of two regulatory approvals, and up to three new launches in 2020. Eli Lilly also raised their dividend 14%. Eli Lilly hit back at Senator Warren calling her criticism of the price of their insulin drug, nonsense.
FedEx (FDX) remains in the dog house. The world's biggest package delivery firm is down 10% after missing earnings, missing sales and lowering guidance. The company is facing lower-than-expected revenue at each of their transportation segments and higher-than-expected expenses driven by continued mix shift. Management stated that current operating results are near a bottom and there are some encouraging signs of improvement in Europe and Asia, but as one analyst put it, FedEx is a show me stock for now.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.